Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bromodomain and PHD finger-containing protein 1 (BRPF1) is a multivalent chromatin regulator and scaffolding protein found in the nucleus and encoded by the BRPF1 gene (chromosome 3p25 in humans). BRPF1 contains two plant homeodomain (PHD) fingers, one bromodomain, and a PWWP domain, which allow it to selectively recognize and bind various epigenetic marks and acetylated lysines on histones. BRPF1 is an essential subunit in several histone acetyltransferase (HAT) complexes—most notably the MOZ/MORF and HBO1 complexes—where it stimulates HAT enzymatic activity and helps target H3K14, H3K23, and other lysines for acetylation. It acts as a master regulator of gene expression, regulating genes such as RUNX1, RUNX2, EZH2, and E2F2. BRPF1 is indispensable for embryonic and neurodevelopment, hematopoiesis, and chromatin organization. Mutations or upregulation of BRPF1 are associated with neurodevelopmental disorders, intellectual disability, facial dysmorphism, and several cancers (notably HCC, leukemia, and medulloblastoma). In cancer, BRPF1 promotes cell proliferation, stemness, and tumorigenicity, making it a validated therapeutic target, with inhibitors such as GSK5959 under investigation. Targeting BRPF1 is complicated by its essential roles in development and normal cell function, raising concerns about therapeutic specificity and safety.
Inhibition of bromodomain binding to acetylated lysines; Suppression of histone acetyltransferase activity through complex disruption; Downregulation of cell proliferation and cancer stemness gene expression
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bromodomain and PHD finger-containing protein 1 (BRPF1).